DEL GIACCO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 4.395
EU - Europa 4.373
AS - Asia 1.307
AF - Africa 126
SA - Sud America 88
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.376
Nazione #
US - Stati Uniti d'America 4.253
IT - Italia 2.396
SE - Svezia 482
CN - Cina 418
GB - Regno Unito 244
DE - Germania 229
IN - India 221
ES - Italia 171
FR - Francia 121
CA - Canada 108
VN - Vietnam 97
NL - Olanda 92
JP - Giappone 87
RU - Federazione Russa 87
AU - Australia 68
HK - Hong Kong 67
BE - Belgio 57
CZ - Repubblica Ceca 55
ID - Indonesia 55
UA - Ucraina 54
FI - Finlandia 51
DK - Danimarca 43
ZA - Sudafrica 41
PT - Portogallo 39
TR - Turchia 39
CH - Svizzera 38
IE - Irlanda 38
IR - Iran 35
KR - Corea 32
BR - Brasile 30
EG - Egitto 30
GR - Grecia 29
PH - Filippine 28
AE - Emirati Arabi Uniti 25
SG - Singapore 25
TH - Thailandia 25
TW - Taiwan 25
MY - Malesia 24
MX - Messico 23
PK - Pakistan 21
MK - Macedonia 20
PL - Polonia 20
AT - Austria 19
SA - Arabia Saudita 19
CL - Cile 18
RO - Romania 18
CO - Colombia 17
IL - Israele 14
DZ - Algeria 12
LT - Lituania 12
NO - Norvegia 12
NZ - Nuova Zelanda 11
PE - Perù 11
RS - Serbia 11
BD - Bangladesh 10
HU - Ungheria 9
BG - Bulgaria 8
EU - Europa 7
TN - Tunisia 7
IQ - Iraq 6
KE - Kenya 6
AR - Argentina 5
KH - Cambogia 5
MW - Malawi 5
UG - Uganda 5
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
LY - Libia 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
CU - Cuba 3
EC - Ecuador 3
JM - Giamaica 3
MV - Maldive 3
QA - Qatar 3
UZ - Uzbekistan 3
BO - Bolivia 2
EE - Estonia 2
JO - Giordania 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
SI - Slovenia 2
TG - Togo 2
TZ - Tanzania 2
VE - Venezuela 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
GU - Guam 1
IS - Islanda 1
KW - Kuwait 1
LI - Liechtenstein 1
Totale 10.367
Città #
Cagliari 1.685
Fairfield 433
Santa Cruz 350
Houston 321
Ashburn 294
Tyresö 253
Woodbridge 246
Buffalo 216
Seattle 206
Ann Arbor 143
Cambridge 137
Wilmington 119
Karlstad 109
Dong Ket 79
Milan 76
Chicago 72
Shanghai 67
San Diego 66
Beijing 65
Rome 61
Mountain View 53
Madrid 49
Helsinki 45
Central 43
Los Angeles 43
Mumbai 43
Stockholm 43
Las Vegas 37
Dublin 31
Brussels 30
Boardman 29
Clearwater 29
Phoenix 28
University Park 28
New York 27
Lyngby 26
Bengaluru 25
Muizenberg 25
Guangzhou 24
Paris 24
Redmond 24
Ottawa 23
Toronto 23
Changsha 22
Council Bluffs 21
Dallas 21
Sydney 20
Duncan 19
Atlanta 18
Shenyang 18
Tokyo 17
Amsterdam 16
Bangkok 16
Barcelona 16
Jakarta 16
Ankara 15
Bogotá 15
Henderson 15
London 15
San Francisco 15
Singapore 15
Wuhan 15
Boydton 14
Chengdu 14
Kolkata 14
Pittsburgh 14
San Jose 14
Florence 13
Osaka 13
Sassari 13
Verona 13
Bangalore 12
Cairo 12
Hangzhou 12
Lisbon 12
Nanjing 12
Naples 12
Saint Petersburg 12
Taipei 12
Torino 12
Athens 11
Glasgow 11
Palermo 11
Riva 11
Twickenham 11
Delhi 10
Frankfurt am Main 10
Kuala Lumpur 10
Lake Forest 10
Melbourne 10
Miami 10
Málaga 10
Provo 10
San Cipriano d'Aversa 10
Skaerholmen 10
Skopje 10
Turin 10
Birmingham 9
Boston 9
Chennai 9
Totale 6.507
Nome #
Severe asthma: entering an era of new concepts and emerging therapies: Highlights of the 4th International Severe Asthma Forum, Madrid, 2018, file e2f56ed8-019b-3eaf-e053-3a05fe0a5d97 1.012
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids, file e2f56ed8-2baa-3eaf-e053-3a05fe0a5d97 555
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma, file e2f56ed9-b2d0-3eaf-e053-3a05fe0a5d97 518
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor, file e2f56ed8-fa6c-3eaf-e053-3a05fe0a5d97 465
Exercise and asthma: an overview, file e2f56ed5-3688-3eaf-e053-3a05fe0a5d97 457
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout, file e2f56ed7-6025-3eaf-e053-3a05fe0a5d97 443
A strategy analysis for genetic association studies with known inbreeding, file e2f56ed3-a34c-3eaf-e053-3a05fe0a5d97 358
Dietary intake and risk of asthma in children and adults: protocol for a systematic review and meta-analysis, file e2f56ed5-3948-3eaf-e053-3a05fe0a5d97 326
Overexpression of the cytokine BAFF and autoimmunity risk, file e2f56ed6-7b51-3eaf-e053-3a05fe0a5d97 298
Baricitinib exposure during pregnancy in rheumatoid arthritis, file e2f56ed9-ab49-3eaf-e053-3a05fe0a5d97 275
Feasibility of the Allergy Questionnaire for Athletes (AQUA©) in pediatric age, file e2f56ed8-5abe-3eaf-e053-3a05fe0a5d97 267
A Traditional Diet Is Associated with a Reduced Risk of Eczema and Wheeze in Colombian Children, file e2f56ed5-62a3-3eaf-e053-3a05fe0a5d97 258
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies, file e2f56ed9-104a-3eaf-e053-3a05fe0a5d97 253
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance, file e2f56ed5-75e7-3eaf-e053-3a05fe0a5d97 239
Changes in symptoms of asthma and rhinitis by sensitization status over ten years in a cohort of young Chilean adults, file e2f56ed5-3945-3eaf-e053-3a05fe0a5d97 216
Towards clinically applicable biomarkers for asthma - An EAACI position paper, file e2f56ed8-019d-3eaf-e053-3a05fe0a5d97 216
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience, file e2f56ed9-5c39-3eaf-e053-3a05fe0a5d97 194
Research needs in allergy: an EAACI position paper, in collaboration with EFA, file e2f56ed3-9a2c-3eaf-e053-3a05fe0a5d97 191
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - an EAACI-ARIA position paper, file e2f56ed9-5944-3eaf-e053-3a05fe0a5d97 189
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report, file e2f56ed3-c00a-3eaf-e053-3a05fe0a5d97 175
Oxidative stress markers in patients with hereditary angioedema, file e2f56ed6-f62c-3eaf-e053-3a05fe0a5d97 171
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management, file e2f56ed9-8614-3eaf-e053-3a05fe0a5d97 162
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study, file e2f56ed7-6d71-3eaf-e053-3a05fe0a5d97 161
Exercise, Asthma and the Olympics: A 2000-year-old tale, file e2f56ed5-7e73-3eaf-e053-3a05fe0a5d97 160
Asthma and dietary intake: an overview of systematic reviews, file e2f56ed5-6633-3eaf-e053-3a05fe0a5d97 157
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment, file e2f56ed3-b964-3eaf-e053-3a05fe0a5d97 147
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy, file e2f56ed5-801e-3eaf-e053-3a05fe0a5d97 147
Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms, file e2f56ed6-47f3-3eaf-e053-3a05fe0a5d97 138
Prioritising research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic Diseases, file e2f56ed8-49f4-3eaf-e053-3a05fe0a5d97 138
Allergy in severe asthma, file e2f56ed5-7cd5-3eaf-e053-3a05fe0a5d97 135
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report, file e2f56eda-97ac-3eaf-e053-3a05fe0a5d97 126
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio, file e2f56ed9-4fd2-3eaf-e053-3a05fe0a5d97 119
Exercise-induced anaphylaxis: an update, file e2f56ed3-c98b-3eaf-e053-3a05fe0a5d97 117
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly, file e2f56ed5-844d-3eaf-e053-3a05fe0a5d97 110
Impaired endothelial function in hereditary angioedema during the symptom-free period, file e2f56ed7-ab24-3eaf-e053-3a05fe0a5d97 104
Fungal allergy in asthma-state of the art and research needs, file e2f56ed5-89b1-3eaf-e053-3a05fe0a5d97 103
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor, file e2f56ed9-4b80-3eaf-e053-3a05fe0a5d97 94
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report, file e2f56ed8-0a27-3eaf-e053-3a05fe0a5d97 91
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies, file e2f56ed9-79e9-3eaf-e053-3a05fe0a5d97 80
Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section, file e2f56eda-4984-3eaf-e053-3a05fe0a5d97 67
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers, file e2f56eda-812c-3eaf-e053-3a05fe0a5d97 64
Differences in lethality and diffusion of Covid-19 in countries using different kinds of vaccines, file 27c96434-7fc5-4686-ab36-f4c404956dec 59
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life, file e2f56eda-6475-3eaf-e053-3a05fe0a5d97 55
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study, file e2f56ed9-ab4b-3eaf-e053-3a05fe0a5d97 54
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome, file 19b46ccc-3a30-46d9-aec2-3934ab4527b6 52
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus, file e2f56eda-365f-3eaf-e053-3a05fe0a5d97 49
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry, file e2f56eda-62ae-3eaf-e053-3a05fe0a5d97 37
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection, file e2f56eda-8b72-3eaf-e053-3a05fe0a5d97 36
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study, file e2f56eda-8cfa-3eaf-e053-3a05fe0a5d97 36
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy, file 16c4bb46-386a-49f7-a6bf-e306a30cda6d 35
Pain and Frailty in Hospitalized Older Adults, file e2f56eda-842a-3eaf-e053-3a05fe0a5d97 34
COVID-19 pandemic and allergen immunotherapy—an EAACI survey, file e2f56eda-859c-3eaf-e053-3a05fe0a5d97 34
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study, file e2f56eda-8be3-3eaf-e053-3a05fe0a5d97 33
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI), file e2f56eda-5e12-3eaf-e053-3a05fe0a5d97 31
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020), file e2f56eda-647e-3eaf-e053-3a05fe0a5d97 29
Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults, file f77927d2-10cd-4416-b64d-35825935ce93 27
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature, file e2f56eda-21ba-3eaf-e053-3a05fe0a5d97 23
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change, file e2f56ed9-7865-3eaf-e053-3a05fe0a5d97 22
Multimodal, open-source big data analysis in asthma: A novel approach to inform public health programming, file 7cddf585-af13-4a2c-963e-48a6a778115a 21
Management of anaphylaxis due to COVID-19 vaccines in the elderly, file e2f56eda-7b24-3eaf-e053-3a05fe0a5d97 20
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force, file e2f56ed6-fdfb-3eaf-e053-3a05fe0a5d97 19
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines, file e2f56eda-8539-3eaf-e053-3a05fe0a5d97 17
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab, file 3d3798f9-5949-45fa-a4fc-392e9a820f7c 16
Mentoring as the cornerstone of continued education in Allergy and Clinical Immunology: 10th anniversary of the EAACI mentorship program, file b5281420-6d47-43f6-bbb7-8cccb5f6615a 16
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather?, file e2f56ed9-938a-3eaf-e053-3a05fe0a5d97 15
COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic, file e2f56eda-2959-3eaf-e053-3a05fe0a5d97 15
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination, file e2f56eda-7e8b-3eaf-e053-3a05fe0a5d97 12
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic, file 448e2ed8-cf19-4774-9d91-5690ab42bf09 10
null, file 44f7819c-db7f-403c-afe5-50cfd5363aae 10
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema, file e2f56ed7-b789-3eaf-e053-3a05fe0a5d97 10
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series, file 8593ac91-8e25-4f2a-9edd-ee03aef561dd 9
HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections, file b48b0230-8998-4fb4-8c60-97c2e286a75f 9
Asthma, allergy and the olympics: A 12-year survey in elite athletes, file e2f56ed4-d7fa-3eaf-e053-3a05fe0a5d97 9
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform, file e2f56ed5-85f6-3eaf-e053-3a05fe0a5d97 8
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype, file e2f56ed6-eee8-3eaf-e053-3a05fe0a5d97 8
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis, file e2f56ed9-9b5a-3eaf-e053-3a05fe0a5d97 8
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations, file e2f56eda-bfb1-3eaf-e053-3a05fe0a5d97 8
Olfactory Function Is Impaired in Patients with Mastocytosis, file e2f56ed9-65e9-3eaf-e053-3a05fe0a5d97 7
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema, file e2f56ed9-8dc9-3eaf-e053-3a05fe0a5d97 7
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma, file e2f56eda-4b33-3eaf-e053-3a05fe0a5d97 7
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy, file e2f56eda-7e8d-3eaf-e053-3a05fe0a5d97 7
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study, file aedb3944-985a-4eaa-bb41-380409865fc0 6
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome, file e2f56ed3-c28b-3eaf-e053-3a05fe0a5d97 6
Aerobic exercise training reduces bronchial hyper-responsiveness and serum pro-inflammatory cytokines in patients with asthma, file e2f56ed5-62a0-3eaf-e053-3a05fe0a5d97 6
The asthma-anxiety connection, file e2f56ed5-6f0d-3eaf-e053-3a05fe0a5d97 6
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema, file e2f56ed8-3d2b-3eaf-e053-3a05fe0a5d97 6
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study, file e2f56eda-46d6-3eaf-e053-3a05fe0a5d97 6
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study, file e2f56eda-a474-3eaf-e053-3a05fe0a5d97 6
Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study, file e0c12e42-4e95-4a07-89cc-2515561da1b2 5
Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement, file e2f56ed5-75eb-3eaf-e053-3a05fe0a5d97 5
Characterization of patients with angioedema without wheals: The importance of F12 gene screening, file e2f56ed7-e755-3eaf-e053-3a05fe0a5d97 5
Is hereditary angioedema related to an increased risk of atherosclerosis?, file e2f56ed8-0195-3eaf-e053-3a05fe0a5d97 5
EAACI Biologicals Guidelines—Recommendations for severe asthma, file e2f56ed9-b101-3eaf-e053-3a05fe0a5d97 5
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines, file e2f56eda-30a0-3eaf-e053-3a05fe0a5d97 5
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients, file f1057a20-67d7-4ee8-b179-5177accc0571 5
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis, file f8c69ee4-e8f3-4d26-b924-dc22ea7e7074 5
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations, file 0402e886-475a-4038-ad9f-82d756e9c5df 4
Cofactors, age at onset, allergic comorbidities and gender are different in patients sensitized to omega-5 gliadin and Pru p 3, file 24ed7101-b99f-4d23-912b-b1ffd96d815c 4
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab, file b563adf7-9b04-4e33-a1a2-54f0bf8fef16 4
A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes, file cd13f5ce-cf3c-4c0c-99e4-8f0033acb814 4
Totale 10.508
Categoria #
all - tutte 24.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019324 0 0 0 0 0 0 0 0 0 85 123 116
2019/20201.593 105 72 71 107 228 232 157 90 130 139 144 118
2020/20212.077 98 150 109 270 299 137 187 126 131 156 186 228
2021/20222.452 200 208 146 282 311 137 133 119 158 110 403 245
2022/20232.210 124 165 477 284 111 113 138 173 162 165 175 123
2023/20241.326 126 94 136 120 158 132 125 139 186 110 0 0
Totale 10.662